143 related articles for article (PubMed ID: 8191544)
1. Other physiological considerations of protective mechanisms of mineralocorticoid action.
Souness GW; Myles K; Morris DJ
Steroids; 1994 Feb; 59(2):142-7. PubMed ID: 8191544
[TBL] [Abstract][Full Text] [Related]
2. The 11 beta-OHSD inhibitor, carbenoxolone, enhances Na retention by aldosterone and 11-deoxycorticosterone.
Morris DJ; Souness GW
Am J Physiol; 1990 Mar; 258(3 Pt 2):F756-9. PubMed ID: 2316675
[TBL] [Abstract][Full Text] [Related]
3. 11 beta-Hydroxysteroid dehydrogenase activity in the renal target cells of aldosterone.
Náray-Fejes-Tóth A; Watlington CO; Fejes-Tóth G
Endocrinology; 1991 Jul; 129(1):17-21. PubMed ID: 2055180
[TBL] [Abstract][Full Text] [Related]
4. The "mineralocorticoid-like" actions conferred on corticosterone by carbenoxolone are inhibited by the mineralocorticoid receptor (type I) antagonist RU28318.
Souness GW; Morris DJ
Endocrinology; 1991 Nov; 129(5):2451-6. PubMed ID: 1657575
[TBL] [Abstract][Full Text] [Related]
5. Effects of carbenoxolone administered acutely to adrenalectomized rats (in vivo) on renal and hepatic handling of corticosterone by 11 beta-hydroxysteroid dehydrogenase.
Latif SA; Semafuko WE; Morris DJ
Steroids; 1992 Oct; 57(10):494-501. PubMed ID: 1455457
[TBL] [Abstract][Full Text] [Related]
6. Differential effect of adrenocorticosteroids on 11 beta-hydroxysteroid dehydrogenase bioactivity at the anterior pituitary and hypothalamus in rats.
Idrus RB; Mohamad NB; Morat PB; Saim A; Abdul Kadir KB
Steroids; 1996 Aug; 61(8):448-52. PubMed ID: 8870163
[TBL] [Abstract][Full Text] [Related]
7. The cortisol-cortisone shuttle and the apparent specificity of glucocorticoid and mineralocorticoid receptors.
Edwards CR; Stewart PM
J Steroid Biochem Mol Biol; 1991 Nov; 39(5B):859-65. PubMed ID: 1659446
[TBL] [Abstract][Full Text] [Related]
8. 11 beta-hydroxysteroid dehydrogenase in vascular smooth muscle and heart: implications for cardiovascular responses to glucocorticoids.
Walker BR; Yau JL; Brett LP; Seckl JR; Monder C; Williams BC; Edwards CR
Endocrinology; 1991 Dec; 129(6):3305-12. PubMed ID: 1954906
[TBL] [Abstract][Full Text] [Related]
9. Distribution of 11 beta-hydroxysteroid dehydrogenase along the rabbit nephron.
Bonvalet JP; Doignon I; Blot-Chabaud M; Pradelles P; Farman N
J Clin Invest; 1990 Sep; 86(3):832-7. PubMed ID: 2394832
[TBL] [Abstract][Full Text] [Related]
10. Interactions between glucocorticoids and mineralocorticoids in the regulation of renal electrolyte transport.
Brem AS; Morris DJ
Mol Cell Endocrinol; 1993 Nov; 97(1-2):C1-5. PubMed ID: 8143889
[TBL] [Abstract][Full Text] [Related]
11. Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle.
Stewart PM; Corrie JE; Shackleton CH; Edwards CR
J Clin Invest; 1988 Jul; 82(1):340-9. PubMed ID: 3164727
[TBL] [Abstract][Full Text] [Related]
12. Apparent mineralocorticoid excess, pseudohypoaldosteronism, and urinary electrolyte excretion: toward a redefinition of mineralocorticoid action.
Funder JW; Pearce PT; Myles K; Roy LP
FASEB J; 1990 Nov; 4(14):3234-8. PubMed ID: 2172062
[TBL] [Abstract][Full Text] [Related]
13. Congenital and acquired syndromes of apparent mineralocorticoid excess.
Edwards CR; Walker BR; Benediktsson R; Seckl JR
J Steroid Biochem Mol Biol; 1993 Apr; 45(1-3):1-5. PubMed ID: 8386930
[TBL] [Abstract][Full Text] [Related]
14. Protective and specificity-conferring mechanisms of mineralocorticoid action.
Morris DJ; Souness GW
Am J Physiol; 1992 Nov; 263(5 Pt 2):F759-68. PubMed ID: 1443166
[TBL] [Abstract][Full Text] [Related]
15. Steroid metabolism determines mineralocorticoid specificity in the toad bladder.
Gaeggeler HP; Edwards CR; Rossier BC
Am J Physiol; 1989 Oct; 257(4 Pt 2):F690-5. PubMed ID: 2508490
[TBL] [Abstract][Full Text] [Related]
16. Distribution of 11 beta-hydroxysteroid dehydrogenase along the rat intestine.
Pácha J; Miksík I
Life Sci; 1994; 54(11):745-9. PubMed ID: 8107525
[TBL] [Abstract][Full Text] [Related]
17. 11-Dehydrocorticosterone in the presence of carbenoxolone is a more potent sodium retainer than corticosterone.
Souness GW; Morris DJ
Steroids; 1993 Jan; 58(1):24-8. PubMed ID: 8430442
[TBL] [Abstract][Full Text] [Related]
18. 11 alpha- and 11 beta-hydroxyprogesterone, potent inhibitors of 11 beta-hydroxysteroid dehydrogenase (isoforms 1 and 2), confer marked mineralocorticoid activity on corticosterone in the ADX rat.
Souness GW; Latif SA; Laurenzo JL; Morris DJ
Endocrinology; 1995 Apr; 136(4):1809-12. PubMed ID: 7895695
[TBL] [Abstract][Full Text] [Related]
19. Expression of 11 beta-OHSD along the nephron of mammals and humans.
Kenouch S; Alfaidy N; Bonvalet JP; Farman N
Steroids; 1994 Feb; 59(2):100-4. PubMed ID: 8191536
[TBL] [Abstract][Full Text] [Related]
20. Distal tubular electrolyte transport during inhibition of renal 11beta-hydroxysteroid dehydrogenase.
Biller KJ; Unwin RJ; Shirley DG
Am J Physiol Renal Physiol; 2001 Jan; 280(1):F172-9. PubMed ID: 11133527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
